| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 | NOTV Inotiv, Inc. | Oakley Daniel Thomas | Chief Operating Officer | Buy | 125 | $1.54 | $192.50 | +1.2% | |
| Mar 1, 2019 | NOTV Inotiv, Inc. | Leasure Robert Jr.63 | President And CEO | Buy | 18,900 | $1.57 | $29,639.00 | +12.6% | |
| Feb 28, 2019 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 37,375 | $20.45 | $764,204.35 | -27.2% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 2,447 | $93.20 | $228,070.19 | -5.7% | |
| Feb 28, 2019 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 200,000 | $2.48 | $495,946.50 | +0.4% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Coward D Scott77 | Chief Administrative Officer | Sell | 2,447 | $93.20 | $228,070.19 | -2.4% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Carey Thomas D. | Director | Sell | 7,500 | $96.00 | $720,000.00 | -15.3% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Johnson Scott C. | SVP - Research And Development | Sell | 1,166 | $93.20 | $108,675.86 | -13.2% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Wyzga Michael S | Director | Sell | 500 | $96.00 | $48,000.00 | -5.5% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Conroy Kevin T81 | President And CEO | Sell | 10,014 | $93.20 | $933,344.86 | -1.1% | |
| Feb 28, 2019 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 75,000 | $20.37 | $1,527,802.50 | -26.8% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Zanotti Katherine S50 | Director | Sell | 25,000 | $92.81 | $2,320,230.85 | -4.8% | |
| Feb 28, 2019 | EXAS Exact Sciences Corp | Doyle James Edward75 | Director | Sell | 2,000 | $96.00 | $192,000.00 | -5.4% | |
| Feb 28, 2019 | WST West Pharmaceutical Services Inc | Zenner Patrick J | Director | Buy | 446 | $97.42 | $43,447.71 | +0.2% | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,957 | $140.55 | $556,159.17 | - | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,459 | $140.24 | $485,076.62 | - | |
| Feb 27, 2019 | DHR Danaher Corp /de/ | Schwieters John T | Director | Sell | 10,578 | $126.81 | $1,341,343.29 | -36.9% | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 2,158 | $141.07 | $304,435.32 | -0.5% | |
| Feb 27, 2019 | DHR Danaher Corp /de/ | Lutz Robert S | Svp-chief Accounting Officer | Sell | 32,822 | $126.97 | $4,167,377.86 | -33.0% | |
| Feb 27, 2019 | DHR Danaher Corp /de/ | Lalor Angela S | SVP, Human Resources | Sell | 4,534 | $127.25 | $576,946.97 | -9.2% | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 513 | $142.49 | $73,094.99 | - | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,312 | $142.06 | $470,515.82 | - | |
| Feb 27, 2019 | DHR Danaher Corp /de/ | Lohr Walter G51 | Director | Sell | 10,578 | $126.85 | $1,341,840.46 | -51.1% | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 3,263 | $141.74 | $462,513.23 | - | |
| Feb 27, 2019 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 2,699 | $141.39 | $381,614.40 | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.